KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medtronic (MDT) Revenue (2016 - 2026)

Medtronic's Revenue history spans 13 years, with the latest figure at $9.0 billion for Q1 2026.

  • On a quarterly basis, Revenue rose 8.74% to $9.0 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $35.5 billion, a 6.88% increase, with the full-year FY2025 number at $33.5 billion, up 3.62% from a year prior.
  • Revenue hit $9.0 billion in Q1 2026 for Medtronic, up from $9.0 billion in the prior quarter.
  • Over the last five years, Revenue for MDT hit a ceiling of $9.0 billion in Q1 2026 and a floor of $7.4 billion in Q3 2022.
  • Historically, Revenue has averaged $8.2 billion across 5 years, with a median of $8.1 billion in 2022.
  • Biggest five-year swings in Revenue: fell 7.71% in 2022 and later increased 8.74% in 2026.
  • Tracing MDT's Revenue over 5 years: stood at $7.6 billion in 2022, then rose by 5.26% to $8.0 billion in 2023, then rose by 5.25% to $8.4 billion in 2024, then grew by 6.64% to $9.0 billion in 2025, then grew by 0.62% to $9.0 billion in 2026.
  • Business Quant data shows Revenue for MDT at $9.0 billion in Q1 2026, $9.0 billion in Q4 2025, and $8.6 billion in Q3 2025.